Vestibular Function Using Mitochondrial Antioxidant Therapy

Vestibular Function Disorder Clinical Trial

Official title:
A Randomized Controlled Study Using Alpha Lipoic Acid and CoQ-10 to Determine if Vestibular Function Can be Improved or Maintained Over the Course of One Year

Status Withdrawn

Clinical Trial Summary

To determine if supplementation with known mitochondrial antioxidants (alpha lipoic acid (ALA) and CoQ-10) will stabilize or improve vestibular function in older adults.

Clinical Trial Description

The subjects will be divided into two groups, half will be given daily supplementation with ALA and CoQ-10. The second group will only receive standard of care treatment, with no study drug intervention. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05945160
Study type	Interventional
Source	The University of Texas Health Science Center at San Antonio
Contact
Status	Withdrawn
Phase	Early Phase 1
Start date	January 2024
Completion date	December 2024

View Details

See also
Status	Clinical Trial	Phase
Enrolling by invitation	`NCT03049683` - Simultaneous Recordings of Cervical and Ocular Vestibular-evoked Myogenic Potentials	N/A
Recruiting	`NCT05045014` - Evaluation of Vestibular Dysfunction or Visuospatial Perception in Individuals With Idiopathic Scoliosis
Enrolling by invitation	`NCT05990023` - The Effect of Computerized Vestibular Function Assessment and Training System Combined With Cognitive/Motor Dual-task	N/A
Not yet recruiting	`NCT06229704` - Vestibular and Postural Function in Children Suspected of Balance Disorders
Completed	`NCT03638310` - Role of Psychiatric Profile in Prehabituated Patients After Vestibular Schwannoma Surgery	N/A